Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30

Rhea-AI Summary

Cardinal Health (NYSE: CAH) will release third-quarter fiscal 2026 results on April 30, 2026 before the New York Stock Exchange opens. A webcast discussion begins at 8:30 a.m. Eastern. Slides and a replay will be available on the company Investor Relations page for 12 months; no access code is required.

Key Figures

Earnings date: April 30, 2026 Webcast time: 8:30 a.m. Eastern Replay availability: 12 months

3 metrics

Earnings date April 30, 2026 Planned Q3 FY2026 results release before NYSE open

Webcast time 8:30 a.m. Eastern Start time for Q3 FY2026 results webcast

Replay availability 12 months Webcast replay and slides on Investor Relations page

Market Reality Check

Price: $206.94 Vol: Volume 1,202,975 is at 0....

low vol

$206.94 Last Close

Volume Volume 1,202,975 is at 0.62x the 20-day average, indicating lighter trading ahead of the earnings date announcement. low

Technical Shares trade above the 200-day MA, with price at $206.30 vs 200-day MA of $182.78, reflecting a longer-term uptrend into the Q3 report date.

Peers on Argus

Key peers show mixed moves: Cencora -2.78%, McKesson -2.14%, Henry Schein +0.62%...

1 Up

Key peers show mixed moves: Cencora -2.78%, McKesson -2.14%, Henry Schein +0.62%, Alcon -0.54%, ResMed -0.67%. With Cardinal Health down 0.69% pre-announcement and limited peer momentum flags, trading appears more stock-specific than a broad sector rotation.

Previous Earnings date Reports

1 past event · Latest: Jan 06 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	Move	Catalyst
Jan 06	Earnings date notice	Neutral	+1.5%	Announced Q2 FY2026 earnings release date and webcast timing details.

Pattern Detected

Limited tag-specific history: the prior earnings-date notice saw a modest +1.47% move, suggesting these scheduling updates have historically prompted only mild positive reactions.

Recent Company History

Over recent months, Cardinal Health has combined strong financial performance with incremental communication milestones. The company raised its fiscal 2026 outlook and reported robust Q2 growth, with double-digit revenue and EPS increases and higher non-GAAP guidance. It also highlighted strategic progress in Specialty and BioPharma Solutions. Against this backdrop, the new Q3 fiscal 2026 earnings date announcement on April 30 continues a pattern of clear scheduling updates similar to the prior Q2 earnings-date notice on January 6, 2026.

Historical Comparison

+1.5% avg move · Past earnings-date news for CAH (1 event) saw an average move of +1.47%, suggesting scheduling annou...

earnings date

+1.5%

Average Historical Move earnings date

Past earnings-date news for CAH (1 event) saw an average move of +1.47%, suggesting scheduling announcements historically triggered modest, orderly reactions.

Represents a continued pattern of timely quarterly earnings-date communications for fiscal 2026.

Regulatory & Risk Context

Active S-3 Shelf

Shelf Active

Active S-3 Shelf Registration 2025-08-12

Cardinal Health has an effective Form S-3ASR shelf filed on August 12, 2025, allowing issuance of various securities over time. Authorized capital includes up to 750 million common shares, 5 million Class B common shares, and 500,000 preferred shares, with no Class B or preferred shares outstanding as of the filing date. The company indicated net proceeds from any offerings would be used for general corporate purposes.

Market Pulse Summary

This announcement sets the timeline for Cardinal Health’s third-quarter fiscal 2026 update, with res...

Analysis

This announcement sets the timeline for Cardinal Health’s third-quarter fiscal 2026 update, with results due on April 30 and a webcast at 8:30 a.m. Eastern. Historically, similar earnings-date notices have produced modest stock moves, such as the prior average move of +1.47%. Investors may watch how upcoming Q3 results align with the raised fiscal 2026 guidance, recent strong revenue and EPS growth, and the company’s ongoing strategic initiatives in Specialty and BioPharma Solutions.

Key Terms

nyse

1 terms

nyse financial

"prior to the opening of trading on the New York Stock Exchange."

A large, regulated marketplace where stocks and other securities are listed and traded, acting like a global auction house that matches buyers and sellers and helps determine share prices. It matters to investors because listing and trading there provide liquidity, price discovery, and regulatory oversight—making it easier to buy or sell holdings and giving companies a visible platform that can affect credibility and access to capital.

AI-generated analysis. Not financial advice.

DUBLIN, Ohio, March 24, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2026 on April 30 as previously indicated, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.

To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No access code is required. Presentation slides and a webcast replay will be available on the Investor Relations page for 12 months.

About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals and specialty products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; a provider of performance and data solutions; and a global manufacturer and distributor of medical and laboratory products. Our company's customer-centric focus drives continuous improvement and leads to innovative solutions that improve people's lives every day. Learn more about Cardinal Health at cardinalhealth.com and in our Newsroom.

Media:	Erich Timmerman
	(614) 757-8231
	Erich.Timmerman@cardinalhealth.com
Investors:	Matt Sims
	(614) 553-3661
	Matt.Sims@cardinalhealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cardinal-health-to-announce-third-quarter-results-for-fiscal-year-2026-on-april-30-302722266.html

SOURCE Cardinal Health, Inc.

FAQ

When will Cardinal Health (CAH) report Q3 FY2026 results?

Cardinal Health will report Q3 FY2026 results on April 30, 2026, before the NYSE opens. According to the company, the release timing is unchanged and the web discussion starts at 8:30 a.m. Eastern on that day.

How can investors access the Cardinal Health (CAH) Q3 FY2026 webcast?

Investors can access the webcast via Cardinal Health's Investor Relations page with no access code required. According to the company, the live discussion and corresponding slide presentation will be posted on the IR site.

What time is the Cardinal Health (CAH) Q3 FY2026 webcast scheduled to begin?

The webcast is scheduled to begin at 8:30 a.m. Eastern on April 30, 2026. According to the company, the discussion will follow the pre-market results release and include a slide presentation.

Will Cardinal Health (CAH) provide slides and a replay of the Q3 FY2026 presentation?

Yes, slides and a replay will be available on the Investor Relations page for 12 months. According to the company, both the presentation slides and a webcast replay will remain accessible for one year.

Is an access code required to join the Cardinal Health (CAH) Q3 FY2026 webcast?

No access code is required to join the webcast on April 30, 2026. According to the company, the webcast and slide materials are publicly accessible via the Investor Relations website.